Literature DB >> 31705761

Reduction of large soft-tissue Gaucheromas with substrate reduction therapy.

Neha Mahajan1, Mikako Warren2, Shoji Yano3.   

Abstract

Soft-tissue masses are rarely seen in Gaucher disease. We previously reported a case of a 30-year-old patient with Gaucher disease type 3, receiving β-glucocerebrosidase enzyme replacement therapy (ERT), who presented with slowly enlarging masses infiltrated with Gaucher cells along her back. Substrate reduction therapy introduced in addition to ERT, resulted in significant reduction of the large masses.
© 2019 SSIEM.

Entities:  

Keywords:  Gaucher disease; Gaucheroma; enzyme replacement therapy (ERT); substrate reduction therapy (SRT)

Mesh:

Substances:

Year:  2019        PMID: 31705761     DOI: 10.1002/jimd.12188

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  1 in total

1.  Large Mesenteric Gaucheroma Responds to Substrate Reduction Therapy: A New Management of Gaucheromas.

Authors:  Shoji Yano; Kathryn Moseley; Neha Mahajan; Mikako Warren; Linda Vachon
Journal:  J Pediatr Genet       Date:  2020-07-29
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.